BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7874688)

  • 1. Cytotoxic and mutagenic effects of ferric nitrilotriacetate on L5178Y mouse lymphoma cells.
    Toyokuni S; Sagripanti JL; Hitchins VM
    Cancer Lett; 1995 Jan; 88(2):157-62. PubMed ID: 7874688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low incidence of point mutations in H-, K- and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate.
    Nishiyama Y; Suwa H; Okamoto K; Fukumoto M; Hiai H; Toyokuni S
    Jpn J Cancer Res; 1995 Dec; 86(12):1150-8. PubMed ID: 8636003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenic effects of ferric nitrilotriacetate (Fe-NTA) on V79 Chinese hamster cells and its inhibitory effects on cell-cell communication.
    Nakatsuka S; Tanaka H; Namba M
    Carcinogenesis; 1990 Feb; 11(2):257-60. PubMed ID: 2302753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress response in iron-induced renal carcinogenesis: acute nephrotoxicity mediates the enhanced expression of glutathione S-transferase Yp isozyme.
    Fukuda A; Osawa T; Oda H; Toyokuni S; Satoh K; Uchida K
    Arch Biochem Biophys; 1996 May; 329(1):39-46. PubMed ID: 8619633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection by alpha G-rutin, a water-soluble antioxidant flavonoid, against renal damage in mice treated with ferric nitrilotriacetate.
    Shimoi K; Shen B; Toyokuni S; Mochizuki R; Furugori M; Kinae N
    Jpn J Cancer Res; 1997 May; 88(5):453-60. PubMed ID: 9247601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-dependent renal accumulation of 4-hydroxy-2-nonenal (HNE)-modified proteins following parenteral administration of ferric nitrilotriacetate commensurate with its differential toxicity: implications for the involvement of HNE-protein adducts in oxidative stress and carcinogenesis.
    Iqbal M; Giri U; Giri DK; Alam MS; Athar M
    Arch Biochem Biophys; 1999 May; 365(1):101-12. PubMed ID: 10222044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA base modifications in renal chromatin of Wistar rats treated with a renal carcinogen, ferric nitrilotriacetate.
    Toyokuni S; Mori T; Dizdaroglu M
    Int J Cancer; 1994 Apr; 57(1):123-8. PubMed ID: 8150530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion and single nucleotide substitution at G:C in the kidney of gpt delta transgenic mice after ferric nitrilotriacetate treatment.
    Jiang L; Zhong Y; Akatsuka S; Liu YT; Dutta KK; Lee WH; Onuki J; Masumura K; Nohmi T; Toyokuni S
    Cancer Sci; 2006 Nov; 97(11):1159-67. PubMed ID: 16925583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol and trimetazidine attenuates ferric nitrilotriacetate-induced oxidative renal injury in rats.
    Singh D; Chander V; Chopra K
    Toxicology; 2003 Sep; 191(2-3):143-51. PubMed ID: 12965117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha-Tocopherol (vitamin-E) ameliorates ferric nitrilotriacetate (Fe-NTA)-dependent renal proliferative response and toxicity: diminution of oxidative stress.
    Iqbal M; Rezazadeh H; Ansar S; Athar M
    Hum Exp Toxicol; 1998 Mar; 17(3):163-71. PubMed ID: 9587785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal cysts and associated renal tumours in male ddY mice injected with ferric nitrilotriacetate.
    Kondo A; Deguchi J; Okada S
    Virchows Arch; 1995; 427(1):91-9. PubMed ID: 7551351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of hepatic and renal metallothionein synthesis by ferric nitrilotriacetate in mice: the role of MT as an antioxidant.
    Min KS; Morishita F; Tetsuchikawahara N; Onosaka S
    Toxicol Appl Pharmacol; 2005 Apr; 204(1):9-17. PubMed ID: 15781289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role of zinc-metallothionein on DNA damage in vitro by ferric nitrilotriacetate (Fe-NTA) and ferric salts.
    Cai L; Tsiapalis G; Cherian MG
    Chem Biol Interact; 1998 Sep; 115(2):141-51. PubMed ID: 9826946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA single- and double-strand breaks produced by ferric nitrilotriacetate in relation to renal tubular carcinogenesis.
    Toyokuni S; Sagripanti JL
    Carcinogenesis; 1993 Feb; 14(2):223-7. PubMed ID: 8435863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of a wide range of C(2-12) aldehydes and C(7-12) acyloins in the kidney of Wistar rats after treatment with a renal carcinogen, ferric nitrilotriacetate.
    Toyokuni S; Luo XP; Tanaka T; Uchida K; Hiai H; Lehotay DC
    Free Radic Biol Med; 1997; 22(6):1019-27. PubMed ID: 9034241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol as target of Fe-NTA-induced lipid peroxidation in rat tissues.
    Rosa A; Deiana M; Corona G; Atzeri A; Incani A; Dessì MA
    Toxicol Lett; 2005 May; 157(1):1-8. PubMed ID: 15795088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nordihydroguairetic acid is a potent inhibitor of ferric-nitrilotriacetate-mediated hepatic and renal toxicity, and renal tumour promotion, in mice.
    Ansar S; Iqbal M; Athar M
    Carcinogenesis; 1999 Apr; 20(4):599-606. PubMed ID: 10223187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention by 2-mercaptoethane sulfonate and N-acetylcysteine of renal oxidative damage in rats treated with ferric nitrilotriacetate.
    Umemura T; Hasegawa R; Sai-Kato K; Nishikawa A; Furukawa F; Toyokuni S; Uchida K; Inoue T; Kurokawa Y
    Jpn J Cancer Res; 1996 Sep; 87(9):882-6. PubMed ID: 8878448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferric nitrilotriacetate promotes N-diethylnitrosamine-induced renal tumorigenesis in the rat: implications for the involvement of oxidative stress.
    Athar M; Iqbal M
    Carcinogenesis; 1998 Jun; 19(6):1133-9. PubMed ID: 9667754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential role of hydrogen peroxide and organic hydroperoxides in augmenting ferric nitrilotriacetate (Fe-NTA)-mediated DNA damage: implications for carcinogenesis.
    Iqbal M; Sharma SD; Mizote A; Fujisawa M; Okada S
    Teratog Carcinog Mutagen; 2003; Suppl 1():13-21. PubMed ID: 12616593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.